A dual-enzyme immunoconjugate system was evaluated for its cytotoxic effect on Candida tropicalis. Glucose oxidase, which generates hydrogen peroxide in the presence of glucose and oxygen, and myeloperoxidase, which catalyzes the oxidation of halides in the presence of hydrogen peroxide, were each conjugated to a C. tropicalis-specffic monoclonal antibody. Neither the glucose oxidase nor the myeloperoxidase conjugates exhibited any significant cytotoxic effect by themselves. A combination of glucose oxidase conjugate (3.2 ng/ml) and myeloperoxidase conjugate (12.8 ng/ml) in the presence of 5 mg of glucose per ml, 150 mM chloride, and 50 FM iodide was cytotoxic to C. tropicalis, killing 99.9% of the treated sample. Flow cytometry was used to characterize the binding of the conjugates to yeast cells and demonstrated that the binding of both conjugates to the yeast cell surface is required for cytotoxicity. In addition, the concentrations of conjugates required for a cytotoxic effect were below the concentrations required to saturate all of the yeast cell surface antibodybinding sites.
characterize the binding of the conjugates to yeast cells and demonstrated that the binding of both conjugates to the yeast cell surface is required for cytotoxicity. In addition, the concentrations of conjugates required for a cytotoxic effect were below the concentrations required to saturate all of the yeast cell surface antibodybinding sites.
Candida tropicalis infections are a significant cause of morbidity and mortality among immunocompromised patients (18, 24) . The role of polymorphonuclear cells (PMNs) in protecting against fungal infections is illustrated by the observation that neutropenic mice are much more susceptible to fatal C. tropicalis infections than healthy animals (5) .
One of the antimicrobial agents contained within the phagosomes of PMNs is myeloperoxidase (MPO). Hydrogen peroxide is generated by activated PMNs during a respiratory burst of metabolism. When hydrogen peroxide is present, MPO catalyzes the oxidation of halide ions which in turn causes oxidative damage and cell death. This hydrogen peroxide-peroxidase system has been shown to be effective against a variety of microorganisms, including fungi (11, 17) . In addition, some MPO is released from the cell during phagocytosis (1) , and since MPO has been shown to bind to Candida cell wall mannans, it has been implicated as a possible antifungal agent outside the PMN as well (25) .
In this report, we describe the characterization and testing of anti-C. tropicalis enzyme immunoconjugates patterned after the oxidase-peroxidase system of PMNs. Okuda et al., using unpurified conjugates consisting of polyclonal anti-C. albicans antibodies coupled to xanthine oxidase and lactoperoxidase, first demonstrated that a peroxide-peroxidase immunoconjugate system could be cytotoxic to yeast cells (19) . We further refined this approach by making anti-C. tropicalis enzyme immunoconjugates by using monoclonal antibodies of defined specificity which could be produced in large amounts and by purifying the conjugates to remove both unconjugated enzyme and antibody. The enzymes chosen for these conjugates, MPO and glucose oxidase (GO), have advantages over lactoperoxidase and xanthine oxidase for use as a potential in vivo therapy. MPO is an enzyme with established antifungal activity (17) . In addition, it has been shown that the antimicrobial activities of MPO and hydrogen peroxide are potentiated by as little as 0.5 mM chloride, well below the physiological levels of chloride in vivo (11) . In contrast, lactoperoxidase requires iodide, bromide, or thiocyanate (which is considered the physiological * Corresponding author. pseudohalide) to potentiate its cytotoxic effect but does not oxidize chloride (23) . GO produces hydrogen peroxide from glucose and oxygen, substrates readily available in vivo, eliminating the need to supply the enzyme with a substrate, as in the case of xanthine oxidase.
MATERIALS AND METHODS
Yeast cultures. C. tropicalis (ATCC 28707) and Saccharomyces cerevisiae (ATCC 9763) were obtained from the American Type Culture Collection (Rockville, Md.). Stock cultures of yeast cells were grown at 37°C on Sabouraud dextrose agar plates (Difco Laboratories, Detroit, Mich.) and stored at 4°C. Before each experiment, a single colony was inoculated into 5 ml of Sabouraud dextrose broth (Difco) and grown for 16 h at 37°C without agitation. An A540 reading of the culture was determined and then diluted with Sabouraud dextrose broth to obtain 1.0 optical density unit (approximately 2 x 107 CFU/ml).
Anti-C. tropicalis monoclonal antibody purification and characterization. The monoclonal antibody used in this study was provided by Chemunex S.A., Maisons Alfort, France. The antibody, designated CTR-35, was generated by the immunization of a mouse with C. tropicalis followed by a standard hybridoma fusion protocol (28) . CTR-35, a subclass 3 immunoglobulin G (IgG), was purified from ascites fluid by protein A affinity chromatography (4) . The binding of the monoclonal antibody was analyzed by using a flow cytometer (FACStar; Becton Dickinson and Co., Paramus, N.J.). A 0.1-ml sample of a yeast culture (1.0 unit of optical density at 540 nm) was incubated for 1 h at 22°C with 1 ,ug of purified antibody in staining buffer (3% dialyzed fetal bovine serum in phosphate-buffered saline). After the samples were washed twice by centrifugation, the bound surface antibody was detected by staining with 5 Enzyme-antibody conjugation. The enzyme-antibody conjugates were made by using a modification of a previously described method (14) . GO Immunoconjugates, evaluated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis on a 3 to 27% acrylamide gradient gel, were free of unconjugated antibody and enzymes (data not shown).
Enzyme assays. MPO activity was measured by a colorimetric assay with o-phenylenediamine (Sigma) as a substrate. Samples (100 ,ul) were diluted in phosphate-citrate buffer (0.103 M sodium phosphate, 0.0486 M citric acid [pH 5.0]) in 96-well enzyme-linked immunosorbent assay plates (Nunc, Roskilde, Denmark). The reaction was started by adding to each well 50 ,ul of phosphate-citrate buffer containing o-phenylenediamine (1 mg/ml) and 0.3% hydrogen peroxide. The rate of color development at 490 nm was measured for 2 min with a Molecular Devices Vm. plate reader. This rate of color development, in mUlli-optical density units per minute, was directly proportional to the enzyme concentration over the range of 0.3 to 20 pLg/ml. GO activity was measured by using essentially the same assay, except the substrate solution consisted of phosphate-citrate buffer containing 4% glucose, 5 U of horseradish peroxidase (Sigma) per ml, and 1 mg of o-phenylenediamine per ml. The GO assay was linear over the range of 0.03 to 1.0 ,ug/ml.
Enzymatic activity determinations showed that on the average, the immunoconjugates consisted of one enzyme molecule coupled to one antibody. The immunoconjugate concentrations used in this report were based on the enzymatic activity. Total protein concentrations were approximately twice the concentrations determined by the enzymatic assay.
Protein assays. Protein concentrations were determined by using the bicinchoninic acid protein assay (Pierce), with bovine serum albumin as a standard (21) .
In vitro assay for Candida cytotoxicity. About 106 CFU of C. tropicalis was collected by centrifugation, suspended in 100 ,ul of staining buffer, and incubated with 25 ,ul of various concentrations of the antibody conjugates, free enzymes, antibody, or buffer control in sterile Eppendorf tubes for 1 h at 22°C. The samples were diluted 250-fold into 1 ml of substrate buffer (3% dialyzed fetal bovine serum, 5 mg of glucose per ml, 50 pM potassium iodide in phosphatebuffered saline) in sterile polypropylene-capped tubes (12 by 75 mm; Falcon; Becton Dickinson). The samples were incubated in a 37°C shaker incubator with the caps loosened to allow gas exchange. After being incubated for 4 h, the samples were chilled to 0°C to stop the enzymatic reaction. Several dilutions for each sample were made, and 75 ,ul was spread onto Sabouraud dextrose agar plates in triplicate. After incubating the plates for 24 to 48 h at 37°C, the number of visible colonies was tabulated and the number of CFU was determined.
Anti-enzyme fluorescence staining reagents. New Zealand White rabbits were immunized with either GO or MPO as described previously (3) . IgG was purified from the immune sera by protein A affinity chromatography (4). Rabbit anti-GO antibodies were conjugated with biotin by using Nhydroxysuccinimidobiotin (8) , and anti-MPO antibodies were labeled with FITC, yielding a fluorochrome/protein ratio of 1.4:1 (6 (Fig. 1) . When the antibody was incubated with an irrelevant yeast, S. cerevisiae, the relative mean signal was only 5.8 ± 3.1, which was equivalent to the background fluorescence (Fig. 1) . Approximately 7% of the S. cerevisiae population exhibited a fluorescence signal above the background fluorescence. This signal was due to nonspecific binding of FITC-labeled goat anti-mouse reagent alone and not to CTR-35 binding. Yeast cells treated with FITC-labeled goat anti-mouse reagent alone or with irrelevant murine IgG and then stained had identical histogram profiles with mean fluorescence values of 6.0 ± 3.0 (Fig. 1) .
Histograms showing a comparison of the binding activity of the enzyme immunoconjugates with unconjugated antibody are shown in Fig. 2 (Fig. 3) . This corresponds to 97.5% killing relative to the untreated culture. Unconjugated MPO (32 ng/ml) plus hydrogen peroxide resulted in 20% killing.
Ten percent or less of the yeast cells were killed when the culture was treated with free MPO, MPO conjugate, or hydrogen peroxide alone (Fig. 3) .
Instead tion with substrate produced maximal killing. We also observed that it was necessary to agitate the samples to achieve maximal killing. Neither enzyme immunoconjugate alone showed any statistically significant killing at a final concentration of 32 ng/ml (enzyme concentration) ( or with any of the combinations found to be cytotoxic for the conjugates.
Flow cytometry analysis of dual-immunoconjugate binding.
We measured the simultaneous binding of the GO and MPO conjugates by flow cytometry by using a dual-color fluorescence staining technique. The yeast cells were incubated with various combinations of GO and MPO conjugates and then stained with an FITC-labeled anti-MPO antibody (green fluorescence) and a biotin-labeled anti-GO antibody plus a phycoerythrin-avidin conjugate (red fluorescence).
Contour density plots showing the simultaneous staining for both enzymes are shown in Fig. 4 Log (12) . A polyclonal anti-C. albicans antibody carrying both xanthine oxidase and lactoperoxidase was shown to be cytotoxic (19) , and immunoconjugates have been used to target amphotericin B-containing liposomes to C. albicans (7) .
The enzyme immunoconjugates used in this study showed only a slight reduction in antigen binding relative to that of native antibody. From (11) . Previous studies have shown that the toxicity of neutrophil MPO occurs only when the MPO is in close proximity to the organism (9, 25) . We showed that as little as 32 ng of MPO immunoconjugate per ml could kill C. tropicalis with the addition of 100 ,uM exogenous H202. Although neutrophil MPO has a fairly high affinity for C. albicans cell wall mannans (Kd, 1.2 x 10-5 M) (26), we were not able to demonstrate any binding of free MPO (32 ng/ml) to C. tropicalis by either cytotoxicity or immunological tests. These results demonstrate that the conjugated MPO has an increased affinity for C. tropicalis relative to that of free MPO while retaining its cytotoxic activity.
In our study, an enzyme immunoconjugate composed of GO was used to generate hydrogen peroxide at the yeast cell surface in close proximity to the MPO immunoconjugate. This system would be expected to be more efficient than adding hydrogen peroxide exogenously where it may decompose before it can interact with the MPO. Similar hydrogen peroxide-generating immunoconjugates by themselves have been shown to be cytotoxic to tumor cells (22) . Even though we could detect bound GO conjugate on the yeast cell surface by using flow cytometry techniques, GO conjugates alone (32 ng/ml) had no effect on C. tropicalis viability. On the basis of this result and the finding that this strain of C. tropicalis was sensitive to 1 mM hydrogen peroxide but resistant to 100 p.M hydrogen peroxide, we concluded that the amount of hydrogen peroxide generated by the GO conjugate was not sufficient to have a cytotoxic effect.
When we tested for the cytotoxic effects of adding both MPO and GO conjugates in tandem, we found that a combination of MPO and GO, 12.8 and 3.2 ng/ml, respectively, was very cytotoxic and resulted in a 99.9% reduction in viable yeast cells. We found that this combination was not the only effective cytotoxic dose in this dual-immunoconjugate system (Table 1) . A range of concentrations, 1.6 to 25.6 ng/ml for the GO conjugate and 6.4 to 25.6 ng/ml for the MPO conjugate, could be effectively used.
When we treated yeast cells with a combination of enzyme immunoconjugates that were found to be cytotoxic, we observed by flow cytometry analysis that both enzyme immunoconjugates were bound to the cell surface. We concluded from this observation that the cytotoxic effect of the dual-immunoconjugate system was due to the combined action of both enzymes bound at the cell surface via the antibody. Both immunoconjugates had similar binding affinities, and neither conjugate bound preferentially to the yeast cells while displacing the other. In addition, flow cytometry analysis showed that yeast cells treated with minimal amounts of each conjugate required for a cytotoxic effect were not saturating all the available antigen-binding sites.
These results have important implications in the use of this dual-enzyme immunoconjugate system in vivo. When a suitable ratio of MPO conjugate and GO conjugate is determined, an excess amount of both conjugates could be administered and the optimal ratio of these conjugates would be maintained on the yeast cell surface.
The MPO-GO enzyme immunoconjugate system offers several advantages over other enzyme immunoconjugate systems as a potential in vivo therapeutic agent. MPO is a natural human enzyme and would be expected to be nonimmunogenic and nontoxic to humans. Although human lactoperoxidase has been isolated in small quantities from the colostrum (15) , the only practical source of large quantities of the enzyme is bovine milk. Lactoperoxidase does not readily oxidize chloride, in contrast to MPO, and must be supplied with iodide, bromide, or thiocyanate to exert its cytotoxic effect (23) . In addition, when we compared the enzymatic activity of MPO with that of lactoperoxidase, our GO is a readily available enzyme, and there are advantages to its use for immunoconjugates because of its enzymatic properties. It can generate hydrogen peroxide from glucose and oxygen, substances readily available in the blood. In other systems that use xanthine oxidase immunoconjugates (19, 22) , xanthine, at concentrations that have yet to be determined, must be supplied for the conjugates to exert a cytotoxic effect. In addition, GO has been shown to have low toxicity in vivo (20) .
The current treatment for candidiasis is amphotericin B therapy. This approach is often ineffective in treating fungal infections in neutropenic and'immunodeficient patients (2) . In addition, amphotericin B has been shown to-be highly toxic to'vital organs (13) . We have demonstrated in an in vitro model system that enzyme immunoconjugates patterned after the hydrogen peroxide-MPO system of neutrophils are effective in killing C. tropicalis. With further development and testing, the enzyme immunoconjugate approach has the potential for becoming an adjunct to current drug treatment, leading to a safe and effective therapy for Candida infections in vivo.
